Stockscreener 앱 받기
1.74
2.79%
-0.05
시간 외 거래:
1.75
0.01
+0.57%
Heron Therapeutics Inc 주식(HRTX)의 최신 뉴스
Heron Therapeutics (NASDAQ:HRTX) Share Price Crosses Above 200 Day Moving AverageHere's What Happened - MarketBeat
An analyst sees good growth prospects for Heron Therapeutics Inc (HRTX) - SETE News
Financial Metrics Check: Heron Therapeutics Inc (HRTX)’s Ratios for Trailing Twelve Months - The Dwinnex
Are Heron Therapeutics Inc (HRTX) shares a good deal now? - US Post News
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by JPMorgan Chase & Co. - MarketBeat
StockNews.com Downgrades Heron Therapeutics (NASDAQ:HRTX) to Hold - MarketBeat
JPMorgan Chase & Co. Has $411,000 Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics (NASDAQ:HRTX) Stock Rating Lowered by StockNews.com - Defense World
HRTX’s Market Whiplash: 15.03% YTD Rise, 15.03% Rise in 30 Days - The InvestChronicle
Great week for Heron Therapeutics, Inc. (NASDAQ:HRTX) institutional investors after losing 26% over the previous year - Simply Wall St
Heron Therapeutics, Inc. (NASDAQ:HRTX) is a favorite amongst institutional investors who own 58% - Yahoo Finance
Heron Therapeutics (NASDAQ:HRTX) Upgraded by StockNews.com to Buy Rating - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Upgraded to Buy at StockNews.com - Defense World
Barclays PLC Purchases 50,109 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Congress Park Capital LLC Grows Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Downgraded by StockNews.com to Hold - Defense World
Heron Therapeutics (NASDAQ:HRTX) Downgraded to "Hold" Rating by StockNews.com - MarketBeat
San Diego Biotech Firm Heron Therapeutics Shifts Operations to North Carolina - MSN
Principal Financial Group Inc. Raises Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Geode Capital Management LLC Sells 66,974 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Jane Street Group LLC Cuts Stock Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Franklin Resources Inc. Sells 6,304,716 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Franklin Resources Inc. Decreases Stock Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics, Inc. (NASDAQ:HRTX) Short Interest Update - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Rating Lowered to “Hold” at StockNews.com - Defense World
This San Diego biotech is moving its HQ to North Carolina - The San Diego Union-Tribune
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by State Street Corp - MarketBeat
Heron Therapeutics to Shift Headquarters from San Diego to Cary, - Hoodline
California public company relocates to North Carolina - The Business Journals
Heron Therapeutics Relocates Headquarters to North Carolina - TipRanks
Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina - PR Newswire
Heron Therapeutics (NASDAQ:HRTX) Cut to "Hold" at StockNews.com - MarketBeat
Fmr LLC Has $859,000 Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Bought by Verition Fund Management LLC - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stake Lowered by Charles Schwab Investment Management Inc. - Defense World
U.S. District Court Upholds Validity of CINVANTI® Patents - The Eastern Progress Online
Exploring Three High Growth Tech Stocks In The United States - Yahoo Finance
Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer - The Eastern Progress Online
StockNews.com Upgrades Heron Therapeutics (NASDAQ:HRTX) to "Buy" - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Rating Increased to Buy at StockNews.com - Defense World
Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance - Kilgore News Herald
Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors - The Eastern Progress Online
1.03%
자본화:
|
볼륨(24시간):